Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/23825306/ below:

Determinants of breast cancer treatment delay differ for African American and White women

Affiliations

• ¹ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Sasha.McGee@alumni.unc.edu

• PMID: 23825306
• PMCID: PMC3719384
• DOI: 10.1158/1055-9965.EPI-12-1432

Item in Clipboard

Sasha A McGee et al. Cancer Epidemiol Biomarkers Prev. 2013 Jul.

• ¹ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Sasha.McGee@alumni.unc.edu

• PMID: 23825306
• PMCID: PMC3719384
• DOI: 10.1158/1055-9965.EPI-12-1432

Item in Clipboard

Background: Timeliness of care may contribute to racial disparities in breast cancer mortality. African American women experience greater treatment delay than White women in most, but not all studies. Understanding these disparities is challenging as many studies lack patient-reported data and use administrative data sources that collect limited types of information. We used interview and medical record data from the Carolina Breast Cancer Study (CBCS) to identify determinants of delay and assess whether disparities exist between White and African American women (n = 601).

Methods: The CBCS is a population-based study of North Carolina women. We investigated the association of demographic and socioeconomic characteristics, healthcare access, clinical factors, and measures of emotional and functional well-being with treatment delay. The association of race and selected characteristics with delays of more than 30 days was assessed using logistic regression.

Results: Household size, losing a job due to one's diagnosis, and immediate reconstruction were associated with delay in the overall population and among White women. Immediate reconstruction and treatment type were associated with delay among African American women. Racial disparities in treatment delay were not evident in the overall population. In the adjusted models, African American women experienced greater delay than White women for younger age groups: OR, 3.34; 95% confidence interval (CI), 1.07-10.38 for ages 20 to 39 years, and OR, 3.40; 95% CI, 1.76-6.54 for ages 40 to 49 years.

Conclusions: Determinants of treatment delay vary by race. Racial disparities in treatment delay exist among women younger than 50 years.

Impact: Specific populations need to be targeted when identifying and addressing determinants of treatment delay.

PubMed Disclaimer

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Study inclusion criteria CNB: core…

Study inclusion criteria CNB: core needle biopsy

Study inclusion criteria CNB: core needle biopsy

• Factors associated with delays to diagnosis and treatment of breast cancer in women in a Louisiana urban safety net hospital.

  Williams DL, Tortu S, Thomson J. Williams DL, et al. Women Health. 2010 Dec;50(8):705-18. doi: 10.1080/03630242.2010.530928. Women Health. 2010. PMID: 21170814

• Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.

  Williams LA, Olshan AF, Tse CK, Bell ME, Troester MA. Williams LA, et al. Cancer Causes Control. 2016 Feb;27(2):259-69. doi: 10.1007/s10552-015-0703-4. Epub 2015 Dec 24. Cancer Causes Control. 2016. PMID: 26705260 Free PMC article.

• Diagnosis and surgical delays in African American and white women with early-stage breast cancer.

  George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, Demissie K. George P, et al. J Womens Health (Larchmt). 2015 Mar;24(3):209-17. doi: 10.1089/jwh.2014.4773. Epub 2015 Feb 4. J Womens Health (Larchmt). 2015. PMID: 25650628 Free PMC article.

• Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

  Adams SA, Hebert JR, Bolick-Aldrich S, Daguise VG, Mosley CM, Modayil MV, Berger SH, Teas J, Mitas M, Cunningham JE, Steck SE, Burch J, Butler WM, Horner MJ, Brandt HM. Adams SA, et al. J S C Med Assoc. 2006 Aug;102(7):231-9. J S C Med Assoc. 2006. PMID: 17319236 Free PMC article. Review.

• Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.

  Tait SD, Ren Y, Horton CC, Oshima SM, Thomas SM, Wright S, Caesar A, Plichta JK, Hwang ES, Greenup RA, Rosenberger LH, DiLalla GD, Menendez CS, Tolnitch L, Hyslop T, Nelson D, Fayanju OM. Tait SD, et al. Cancer. 2021 Jul 15;127(14):2515-2524. doi: 10.1002/cncr.33473. Epub 2021 Apr 7. Cancer. 2021. PMID: 33826758 Free PMC article. Review.

• Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors.

  Pinheiro LC, Samuel CA, Reeder-Hayes KE, Wheeler SB, Olshan AF, Reeve BB. Pinheiro LC, et al. Breast Cancer Res Treat. 2016 Oct;159(3):535-43. doi: 10.1007/s10549-016-3965-y. Epub 2016 Sep 1. Breast Cancer Res Treat. 2016. PMID: 27585477 Free PMC article.

• Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation.

  Butler PD, Morris MP, Momoh AO. Butler PD, et al. Ann Surg Oncol. 2021 Oct;28(11):6099-6108. doi: 10.1245/s10434-021-10487-z. Epub 2021 Jul 21. Ann Surg Oncol. 2021. PMID: 34287788 Review.

• Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.

  Vidal G, Bursac Z, Miranda-Carboni G, White-Means S, Starlard-Davenport A. Vidal G, et al. Cancer Med. 2017 Jul;6(7):1776-1786. doi: 10.1002/cam4.1117. Epub 2017 Jun 14. Cancer Med. 2017. PMID: 28612435 Free PMC article.

• Investigating Associations Between Health-Related Quality of Life and Endocrine Therapy Underuse in Women With Early-Stage Breast Cancer.

  Pinheiro LC, Wheeler SB, Reeder-Hayes KE, Samuel CA, Olshan AF, Reeve BB. Pinheiro LC, et al. J Oncol Pract. 2017 May;13(5):e463-e473. doi: 10.1200/JOP.2016.018630. Epub 2017 Mar 14. J Oncol Pract. 2017. PMID: 28291383 Free PMC article.

• Assessing health disparities in breast cancer incidence burden in Tennessee: geospatial analysis.

  Salmeron B, Mamudu L, Liu X, Whiteside M, Williams F. Salmeron B, et al. BMC Womens Health. 2021 May 3;21(1):186. doi: 10.1186/s12905-021-01274-9. BMC Womens Health. 2021. PMID: 33941168 Free PMC article.

1. 1. Berz JPB, Johnston K, Backus B, Doros G, Rose AJ, Pierre S, et al. The influence of black race on treatment and mortality for early-stage breast cancer. Medical care. 2009;47:986–992. - PubMed
2. 1. Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: A population-based analysis. J Natl Cancer Inst. 2009;101:993–1000. - PMC - PubMed
3. 1. Albain KS, Unger JM, Crowley JJ, Coltman CA, Jr., Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group. J Natl Cancer Inst. 2009;101:984–992. - PMC - PubMed
4. 1. Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: A population-based study. Cancer detection and prevention. 1999;23:463–473. - PubMed
5. 1. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in african american and white american patients with breast cancer: Ethnicity compared with socioeconomic status. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:1342–1349. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3